| 摘要 |
The present invention relates to a composition containing osmotin peptide as an active ingredient for the prevention, improvement or treatment of diabetes. Specifically, the present invention provides a composition containing osmotin peptide as an active ingredient for the prevention, improvement or treatment of diabetes by having confirmed that blood glucose content markedly decreased in a model mouse which had obesity induced therein, and then was treated with osmotin peptide. |
